Ritter Pharmaceuticals Stock Price - RTTR

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Ritter Pharmaceuticals Inc RTTR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.1945 0.00 0.00 0.00 0.1945 05:44:27
Bid Price Ask Price Spread Spread % News
0.175 0.1939 0.0189 9.75% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Ritter Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.83M 9.43M $ -16.87M -3.64 - 9.30M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.40%

more financials information »

Ritter Pharmaceuticals News

Date Time Source News Article
11/26/201909:01Edgar (US Regulatory)Current Report Filing (8-k)
11/14/201906:07Edgar (US Regulatory)Quarterly Report (10-q)
11/14/201906:01Edgar (US Regulatory)Current Report Filing (8-k)
11/13/201919:35GlobeNewswire Inc.Ritter Pharmaceuticals Reports Financial Results for the..
11/07/201906:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/07/201906:02Edgar (US Regulatory)Current Report Filing (8-k)
11/01/201916:16Edgar (US Regulatory)Current Report Filing (8-k)

Latest RTTR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RTTR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.19470.2640.170.19108111,389,823-0.0002-0.1%
1 Month0.27310.27310.16440.1991483583,237-0.0786-28.78%
3 Months0.300.4450.16440.30182531,097,913-0.1055-35.17%
6 Months0.831.270.16440.4519335656,092-0.6355-76.57%
1 Year0.89981.350.16440.6065241539,022-0.7053-78.38%
3 Years25.9037.500.16443.81445,547-25.71-99.25%
5 Years50.0054.9990.16445.61328,325-49.81-99.61%

Ritter Pharmaceuticals Description

Ritter Pharmaceuticals Inc develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The company is further exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treating/preventing a variety of conditions including: gastrointestinal diseases, immuno-oncology, metabolic, and liver disease.
Your Recent History
NASDAQ
RTTR
Ritter Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191206 11:24:17